Myeloma Center
April 24, 2026
Behind the Scenes
Majid Asgari, Ph.D. Majid Asgari, Ph.D., is a postdoctoral fellow in the UAMS College of Medicine Department of Internal Medicine. He earned his doctorate in medical biotechnology from the Pasteur Institute of Iran in 2021 and joined the UAMS Myeloma Center in 2024 in the lab of research director Fenghuang “Frank” Zhan, M.D., Ph.D. His…
Publications
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages Blood Cancer Journal November 2024 Primary authors: Yan Cheng, Ph.D.; Fumou Sun, Ph.D. Tumor immune microenvironmental alterations occur early in multiple myeloma development. In this study, we aim to systematically characterize the tumor immune microenvironment (TME) and the tumor-immune interactions from precursor stages,…
Infusion B: A Welcoming Setting for Blood Cancer Patients
Five years after its opening, Infusion B at the Winthrop P. Rockefeller Cancer Institute continues to play a vital role in the transformational care that blood cancer patients receive at the University of Arkansas for Medical Sciences (UAMS). The state-of-the-art center, which opened in late 2020 on the institute’s sixth floor, sees patients with such…
Myeloma Patient Thankful for Chance to Participate in Clinical Trial
Gary Robertson thinks his multiple myeloma diagnosis came at good time, if such a thing is possible. “I’d never any had health issues to speak of,” said the 73-year-old Robertson, whose multiple myeloma diagnosis coincided with a groundbreaking clinical trial at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute. His…
Cancer Institute’s Clinical Research Team Guides Myeloma Clinical Trials
The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) is the state’s leader in cancer clinical trials. Clinical trials are conducted for purposes such as studying new drugs or drug combinations, reviewing a new method of performing surgeries or using existing treatments, or researching ways to prevent diseases. The…
Partners in Care: Cytogenetics Laboratory Finds Clues to Myeloma Treatment
The Myeloma Center began at the University of Arkansas for Medical Sciences (UAMS) in 1989. The Cytogenetics Laboratory has been supporting them since the beginning. The Cytogenetics Laboratory, located at the Freeway Medical Tower in Little Rock off UAMS’ main campus, is part of the Clinical Laboratory under the UAMS College of Medicine Department of…
Early Experiences Set Myeloma Center Nurse on Her Current Course
Kayla Hefner, RN, has been in health care nearly her entire life. “My mother worked in the human resources department at the old Doctors Hospital in Little Rock,” said Hefner, a nurse with the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). “As a teenager,…
Cancer Institute Spotlight Shines on Myeloma Center Physician
Carolina Schinke, M.D., one of the exceptional clinicians and researchers at the University of Arkansas for Medical Sciences (UAMS) Myeloma Center, has been recognized for her outstanding work. The Winthrop P. Rockefeller Cancer Institute hosted its annual research retreat on May 7, 2025, at the Robinson Center in downtown Little Rock, at which Schinke was…
Volunteers Earn MVP Honors from Myeloma Patients
Myeloma patients are not alone as they go through their first day of appointments at the University of Arkansas for Medical Sciences (UAMS). A group of dedicated and enthusiastic volunteers known as Most Vital Pals (MVPs) help guide new patients around UAMS’ campus. The MVP program is part of the Winthrop P. Rockefeller Cancer Institute…
Myeloma Center Research Director Invested into Endowed Chair
Fenghuang “Frank” Zhan, M.D., Ph.D., research director of the Winthrop P. Rockefeller Cancer Institute’s Myeloma Center at the University of Arkansas for Medical Sciences (UAMS), is the initial holder of the Dr. Bart Barlogie Chair for Myeloma Research. Zhan, a tenured professor of medicine whose research focuses on identifying treatment approaches to overcome drug resistance…
Next page